Implementation of pan-enteric PCR screening at a UK general district hospital – benefits, pitfalls and lessons learnt
Implementation of pan-enteric PCR screening at a UK general district hospital – benefits, pitfalls and lessons learnt Presented by Elisabetta Savanco Senior Biomedical Scientist in Medical Microbiology at Blackpool Teaching Hospitals NHS Foundation Trust Gastroenteritis is a significant socioeconomic burden. It is crucial to identify or exclude infectious causes of gastroenteritis, as this informs treatment…
Read MoreMolecular Testing for Intestinal Protozoa: How a Laboratory Developed Test Compares to One That Is FDA-Cleared
Molecular Testing for Intestinal Protozoa: How a Laboratory Developed Test Compares to One That Is FDA-Cleared Presented by Dr Susan Madison-Antenucci Lab Chief of Bloodborne and Parasitic Diseases, New York State Department of Health, Wadsworth Center Assistant Professor – Biomedical Sciences. Assistant Professor – Environmental Health Sciences, College of Integrated Health Sciences, University at Albany.…
Read MoreASM-Microbe 2024
Join the Genetic Signatures team at ASM Microbe from June 13-17 2024 in Atlanta, Georgia, United States. We will be show casing our recently FDA 510(k) cleared EasyScreen® Gastrointestinal Parasite Detection Kit and automated workflow at booth 1610. To learn more about this technology and the solutions offered by Genetic Signatures, you can visit our…
Read MoreFDA Clears Genetic Signatures’ Molecular Diagnostic Solution for Gastrointestinal Parasites
A comprehensive and uniquely differentiated multiplex PCR test for gastrointestinal parasites Newtown, New South Wales, Australia, 4th Jun 2024 – Genetic Signatures Limited (ASX: GSS), a leader in molecular diagnostic solutions for infectious disease, announces United States (US) Food and Drug Administration (FDA) 510(k) clearance for its EasyScreen™ Gastrointestinal Parasite Detection Kit and GS1 automated…
Read More